Positive ion mode significant differential metabolites (Fold Change greater than 2 or less than 0.5). by Peng-fei Han (694841)

Epac activation increased MYPT phosphorylation via PLC/PKC. by Yoshiki Ohnuki (576298)

Subjects:

Phosphorylation status of myofilament proteins prepared from Epac1TG. by Yoshiki Ohnuki (576298)

Subjects:

Epac activation with 8CPT-AM induced RLC phosphorylation in the perfused hearts. by Yoshiki Ohnuki (576298)

Subjects:

Epac activation increased RLC phosphorylation via PLC/PKC. by Yoshiki Ohnuki (576298)

Subjects:

Obesity prevalence of NYC public school K-8 students by race/ethnicity and home-neighborhood poverty level, 2019–20. by Kira L. Argenio (18563302)

Subjects:

Results of the M-K test in different seasons (significant level is 0.05). by Wang Runke (13256851)

Geniposide (Gen) significantly decreased the content of Hyp in bleomycin-induced PF mice’s lung tissue. by Jian-Bin Yin (19556105)

Decrease in mitochondrial membrane potential levels seen in a model of hyperoxia-induced BPD. by Yifan Luo (5868083)

Proportions of intervals where cytokines change varies between cytokines. by Jordan K. Abbott (8934239)

Subjects:

Data Sheet 1_Secretoneurin plasma levels are decreased after catheter ablation for atrial fibrillation—patients with AF produce lower SN levels than healthy individuals: the SAFE r... by Jiří Plášek (21805048)

“…</p>Conclusion<p>Plasma secretoneurin levels are decreased after catheter ablation for atrial fibrillation; patients with AF produce lower SN levels than healthy individuals. …”

Energy efficiency variation across cities in the Greater Bay Area. by YanFei Lei (19532983)

Subjects:

List of metabolites with significantly increased or decreased accumulation in CSF of dKO vs WT rats. by Samit Ganguly (1792294)

The TRPA1 protein level in the heart from older mice is decreased. by Shuangtao Ma (704707)

Fig 1 - by Marc S. Penn (16624541)

Subjects:

Causes of death as recorded in medical chart reported as percent of total deaths. by Marc S. Penn (16624541)

Subjects:

Characteristics of baseline MPO cohort and “change in MPO cohort” (patients with multiple MPO measures). by Marc S. Penn (16624541)

Subjects:

S1 Data - by Marc S. Penn (16624541)

Subjects:

Fig 2 - by Marc S. Penn (16624541)

Subjects:

pDNA-PK levels are decreased in absence of cGAS. by Elona Gusho (4688170)